FDA Clears Mayo Clinic for Manufacture of NurOwn and Participation in BrainStorms Phase 2 ALS Trial

Posted by admin
Aug 18 2014

NEW YORK, NY and PETACH TIKVAH, Israel /ACCESSWIRE / August 18, 2014 / BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced …

Read more:
FDA Clears Mayo Clinic for Manufacture of NurOwn and Participation in BrainStorms Phase 2 ALS Trial


Incoming Post Search Feeds:
stem cells periodontal regeneration
regeneus
Spinal Cord Surgery India
stemgenics inc philippines
gdf 11
stem cell research, BETTER SEX
search adult video
adivive fat transfer stem cells
stem cell villa medica germany dureza
stromal vascular fraction osteoarthritis

Related Post

Comments are closed.